Skip to main content
SY
NASDAQ Technology

So-Young Q2 Revenue Jumps 33% to RMB505M; Aesthetic Treatment Revenue Up 130%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.6
Mkt Cap
$240.913M
52W Low
$1.28
52W High
$4.75
52W Position info
103% above low
Off High info
45% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

SY has more than doubled off its 52-week low of $1.28.

Summary

So-Young reported Q2 2026 revenue of RMB505.2M, up 33.4% YoY, with aesthetic treatment services revenue up 129.5% to RMB331.4M. Net loss narrowed 37% to RMB22.7M, and Q3 guidance implies ~92–97% growth in aesthetic treatment revenue.


Key Events · Earnings and Guidance · SY

  • Q2 Revenue Hits Record RMB505.2M

    Total revenue rose 33.4% YoY to RMB505.2M (US$74.5M), driven by aesthetic treatment services revenue of RMB331.4M, up 129.5% YoY and exceeding the high end of guidance.

  • Net Loss Narrows 37%

    Net loss attributable to So-Young was RMB22.7M (US$3.3M), down from RMB36.0M a year earlier. Non-GAAP net loss was RMB21.0M.

  • Branded Center Expansion Accelerates

    65 branded centers across 18 cities; 47 centers profitable and 51 generated positive operating cash flow in Q2. Same-store sales growth was 52% vs 14% a year ago. Verified treatment visits rose 145% YoY to 165,200.

  • Q3 Guidance Implies ~92–97% Growth

    Company expects Q3 2026 aesthetic treatment services revenue of RMB352.0M–RMB362.0M, representing 91.7%–97.2% YoY growth.


Analysis · SY · Technology

So-Young delivered its strongest quarter yet, with total revenue up 33.4% year-over-year to RMB505.2 million, driven by a 129.5% surge in aesthetic treatment services revenue to RMB331.4 million. The company narrowed its net loss by 37% to RMB22.7 million and guided Q3 aesthetic treatment revenue to RMB352–362 million, implying 91.7%–97.2% growth. The branded center expansion is working — 47 of 65 centers are profitable and same-store sales grew 52% — but the legacy information and reservation services business continues to shrink, down 35% year-over-year. With RMB848.2 million in cash, the company has ample runway to fund its pivot toward owned clinics.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SY was trading at $2.60 on NASDAQ in the Technology sector, with a market capitalization of approximately $240.9M. The 52-week trading range was $1.28 to $4.75. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SY - Latest Insights

SY
Aug 31, 2026, 6:11 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $2.76 info
Change: +$0.080 (+3%) info
Market Cap: $272.665M info
SY
May 22, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.33
Real-time Price: $2.76 info
Change: +$0.430 (+18%) info
Market Cap: $272.665M info
SY
May 22, 2026, 5:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.46
Real-time Price: $2.76 info
Change: +$0.300 (+12%) info
Market Cap: $272.665M info
SY
Apr 23, 2026, 6:20 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $2.78
Real-time Price: $2.76 info
Change: -$0.020 (-0.72%) info
Market Cap: $272.665M info
SY
Mar 25, 2026, 5:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.99
Real-time Price: $2.76 info
Change: -$0.230 (-8%) info
Market Cap: $272.665M info